ENTtoday
  • Home
  • COVID-19
  • Practice Focus
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Departments
    • Issue Archive
    • TRIO Best Practices
      • Allergy
      • Facial Plastic/Reconstructive
      • Head and Neck
      • Laryngology
      • Otology/Neurotology
      • Pediatric
      • Rhinology
      • Sleep Medicine
    • Career Development
    • Case of the Month
    • Everyday Ethics
    • Health Policy
    • Legal Matters
    • Letter From the Editor
    • Medical Education
    • Online Exclusives
    • Practice Management
    • Resident Focus
    • Rx: Wellness
    • Special Reports
    • Tech Talk
    • Viewpoint
    • What’s Your O.R. Playlist?
  • Literature Reviews
    • Allergy
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Events
    • Featured Events
    • TRIO Meetings
  • Contact Us
    • About Us
    • Editorial Board
    • Triological Society
    • Advertising Staff
    • Subscribe
  • Advertise
    • Place an Ad
    • Classifieds
    • Rate Card
  • Search

Cholesteatoma: Is a Second Stage Necessary?

by Jarrod A. Keeler, MD, and David M. Kaylie, MD • February 20, 2017

  • Tweet
  • Email
Print-Friendly Version

Background

© Welleschik/Wikipedia

Cholesteatoma
© Welleschik/Wikipedia

Cholesteatoma can be a difficult disease to treat because the underlying cause of the disease, Eustachian tube dysfunction, is generally not addressed. This can lead to recurrent disease. Surgical resection of cholesteatoma can also be quite challenging, and residual cholesteatoma is often present after surgery.

You Might Also Like

  • Can Radiologic Imaging Replace Second-Look Procedures for Cholesteatoma?
  • Intraoperative Endoscope Use Reduces Cholesteatoma Recurrence, Cost
  • The Case for Second Look Procedures
  • The Great Debate: Canal-wall-up vs. canal-wall-down surgery for pediatric cholesteatomas
Explore This Issue
February 2017

The term recidivism is frequently used to describe both recurrent and residual cholesteatoma. The total recidivism rate has been found in various studies to be between 10% and 70%. The primary treatment has been debated for decades, with recommendations for canal wall down (CWD), canal wall up (CWU), staged procedures, and endoscopic procedures. Historically, CWD procedures have lower overall recidivistic rates. CWU with second-look procedures have similar recidivistic rates.

Recently, some have advocated foregoing the second look in favor of a planned single-stage procedure with CWD procedures for those with known extensive disease, and CWU procedures for those whom the cholesteatoma can be removed completely. The reasoning is that only residual disease is addressed by second-look procedures; if the disease is entirely removed in the primary procedure, second-stage procedures should not be necessary. To minimize any unnecessary procedures, some surgeons recommend two-stage procedures only when cholesteatoma persistence is uncertain. As a response, our group asks this question: “Is a second stage necessary to treat cholesteatoma in canal wall up procedures?”

Best Practice

Second-look procedures keeps overall recurrence from residual cholesteatoma rates similar to that of CWD procedures. In the four studies presented here, 1,250 patients were treated with CWU procedures and 49 (3.9%) unexpected residual cholesteatomas were found. Four hundred seventy-eight planned second-look procedures were performed and 156 (32.6%) residual cholesteatomas were found. Therefore, more than 67% of the second-look procedures were unnecessary.

Finally, new methods, such as nonecho planar imaging magnetic resonance imaging (MRI) for evaluation of postoperative ears, offer highly sensitive and specific evaluation of recurrent and residual cholesteatoma. Use of this imaging modality may help prevent unnecessary surgery for patients when there is concern for residual or recurrent cholesteatoma.

Recently, many have favored a tailored approach, with a second look reserved for those patients when cholesteatoma was thought to be left behind at the primary surgery.

The studies presented here show that a selective approach to staging cholesteatoma surgery, in both adults and pediatric patients, is effective and appropriate and will reduce unnecessary procedures (Laryngoscope. 2016;126: 1499–1500).

Filed Under: Otology/Neurotology, TRIO Best Practices Tagged With: Cholesteatoma, CWD procedure, outcome, residual cholesteatoma, treatmentIssue: February 2017

You Might Also Like:

  • Can Radiologic Imaging Replace Second-Look Procedures for Cholesteatoma?
  • Intraoperative Endoscope Use Reduces Cholesteatoma Recurrence, Cost
  • The Case for Second Look Procedures
  • The Great Debate: Canal-wall-up vs. canal-wall-down surgery for pediatric cholesteatomas

The Triological SocietyENTtoday is a publication of The Triological Society.

The Laryngoscope
Ensure you have all the latest research at your fingertips; Subscribe to The Laryngoscope today!

Laryngoscope Investigative Otolaryngology
Open access journal in otolaryngology – head and neck surgery is currently accepting submissions.

Classifieds

View the classified ads »

TRIO Best Practices

View the TRIO Best Practices »

Top Articles for Residents

  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Why More MDs, Medical Residents Are Choosing to Pursue Additional Academic Degrees
  • What Physicians Need to Know about Investing Before Hiring a Financial Advisor
  • Tips to Help You Regain Your Sense of Self
  • Should USMLE Step 1 Change from Numeric Score to Pass/Fail?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Vertigo in the Elderly: What Does It Mean?
    • Experts Delve into Treatment Options for Laryngopharyngeal Reflux
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Weaning Patients Off of PPIs
    • Vertigo in the Elderly: What Does It Mean?
    • New Developments in the Management of Eustachian Tube Dysfunction
    • Some Laryngopharyngeal Reflux Resists PPI Treatment
    • Eustachian Tuboplasty: A Potential New Option for Chronic Tube Dysfunction and Patulous Disease
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment
    • Podcasts Becoming More Popular Method of Education for Otolaryngologists
    • How to Embrace Optimism in the Midst of the COVID-19 Pandemic
    • Tips on How to Approach Conversations with Patients about the COVID-19 Vaccine
    • Steps You Should Take to Protect Your Voice and Hearing During Telemedicine Sessions
    • Routine Postoperative Adjunct Treatments Unnecessary for Idiopathic Cerebrospinal Fluid Leaks

Polls

Have you spoken with your patients about receiving the COVID-19 vaccine?

View Results

Loading ... Loading ...
  • Polls Archive
  • Home
  • Contact Us
  • Advertise
  • Privacy Policy
  • Terms of Use

Visit: The Triological Society • The Laryngoscope • Laryngoscope Investigative Otolaryngology

Wiley
© 2021 The Triological Society. All Rights Reserved.
ISSN 1559-4939

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.